Advancements in CRISPR gene editing offer hope for sickle cell disease treatment
TL;DR Summary
CRISPR Therapeutics, along with two other companies, faced the challenge of choosing which genetic disease to target first with the revolutionary gene-editing tool CRISPR-Cas9. After considering various options, they decided to focus on sickle cell disease, making it the first disease to be treated using CRISPR.
Topics:health#crispr#gene-editing#genetic-diseases#medical-breakthrough#science-and-technology#sickle-cell
- Why sickle cell disease is getting the first CRISPR treatment STAT
- Crispr gene editing technology could transform medicine | FT Tech Financial Times
- I received the new gene-editing drug for sickle cell disease. It changed my life. MIT Technology Review
- 'Transformative' genetic therapies for sickle cell disease on the horizon Detroit News
- FDA Action Alert: Vertex/CRISPR, Arcutis and Optinose BioSpace
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
63%
123 → 46 words
Want the full story? Read the original article
Read on STAT